A multi-institution research team led by Georgetown University Medical Center has developed and validated a model estimating ...

DeepScribe, the ambient AI leader for oncology, marked a major milestone with its ambient AI set to document more than three ...

The model, trained and tested using anonymized medical data from the UK and Denmark, is able to predict health events over a ...

Fibromyalgia was considered a comorbidity rather than a rheumatic disease, but was present in about 10% of patients. Other common comorbidities included mood and anxiety disorders. More than 60% of ...

Conclusions: There is a potential mismatch between what clinicians identify as important in determining palliative care need and final eligibility determinations. Patients with dementia were less ...

Every advance against cancer reveals the same truth: this is a disease that has “learned” to fight back. There are more than 200 types of cancer, and the biology of a tumor is constantly changing.

The complex sugar molecules that festoon our cells are often treated as little more than biological decoration. A new study suggests they hold hidden patterns—distinct signatures that can separate one ...

Google DeepMind said Wednesday that its latest biological artificial-intelligence system has generated and experimentally confirmed a new hypothesis for cancer treatment, a result the company calls “a ...

Guardant Health has the first FDA-approved liquid biopsy that can spot colon cancer. Co-CEO Helmy Eltoukhy tells Business Insider the story of how they used Silicon Valley strategy to build it. This ...

New Delhi: India is set to tighten rules on the sale and distribution of four crucial life-saving medicine categories—vaccines, antimicrobials, narcotic and psychotropic drugs, and anti-cancer ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...